22 June 2023 - In the first half of 2023, the Ministry of Health and Welfare set up a public private discussion group with the pharmaceutical industry to discuss drug price compensation plan for innovative new drugs, which results will be announced soon.

Furthermore, the expansion of the list of drugs exempt from pharmacoeconomic evaluation in January 2023 facilitated a more efficient listing process.

Read Lexology article